SavedAdd your journal

Journals / Cukurova Medical Journal / 2020 / Cilt: 45 - Sayı: 3

Cardiovascular changes in genetic absence epileptic WAG/Rij rats: Effects of chronic ethosuximide treatment

Genetik absans epilepsili WAG/Rij sıçanlarda kardiyovasküler değişiklikler: Kronik etosüksimid tedavisinin etkileri

Tuğçe DEMİRTAŞ ŞAHİN
Tijen UTKAN
Ayşe KARSON
Yusufhan YAZIR
Erdal KARAOZ
Pages
769–777
Publication Date
2020-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

T-type Ca++ channels may play a role in these changes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to investigate the effects of chronic ethosuximide (ETX) treatment on absence seizures and cardiovascular parameters in WAG/Rij rats with genetic absence epilepsy.Materials and Methods: Eight-weeks old, male Wistar and WAG/Rij rats were divided into four groups (n=20): Wistar control, Wistar ETX, WAG/Rij control and WAG/Rij ETX.
📊
Key Findings & Data:ETX groups received chronic ETX treatment (oral, 300 mg/kg/day) for 3 months.
💡
Conclusion & Impact:T-type Ca++ channels may play a role in these changes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Absence epilepsy · WAG/Rij · ethosuximide

Abstract

Purpose: The aim of this study was to investigate the effects of chronic ethosuximide (ETX) treatment on absence seizures and cardiovascular parameters in WAG/Rij rats with genetic absence epilepsy.Materials and Methods: Eight-weeks old, male Wistar and WAG/Rij rats were divided into four groups (n=20): Wistar control, Wistar ETX, WAG/Rij control and WAG/Rij ETX. ETX groups received chronic ETX treatment (oral, 300 mg/kg/day) for 3 months. At the end of the 3-month-treatment period; the total and mean duration, also number of spike wave discharges (SWDs) were evaluated using EEG recordings. Mean arterial blood pressure (MAP) and heart rate (HR) measurements were performed. Results: ETX treatment significantly decreased the duration and frequency of SWDs in WAG/Rij rats. MAP in WAG/Rij control group was markedly higher than Wistar control group. In Wistar ETX group, HR was significantly slower than Wistar control group. KCl-induced contraction response enhanced in Wistar ETX group and diminished in WAG/Rij control group compared to Wistar control group. Conclusion: Increased MAP and vascular reactivity in WAG/Rij rats. ETX treatment did not alter cardiovascular parameters in WAG/Rij rats whereas the treatment decreased the HR and vascular reactivity without affecting MAP in Wistar rats. T-type Ca++ channels may play a role in these changes.

Özet

Amaç: Bu çalışmada, genetik absans epilepsili WAG/Rij sıçanlarda kronik etosüksimid (ETS) tedavisinin absans nöbetler ve gözlenebilecek olası kardiyovasküler değişiklikler üzerindeki etkilerinin araştırılması amaçlanmıştır.Gereç ve Yöntem: İki aylık erkek Wistar ve WAG/Rij sıçanlar; Wistar kontrol, Wistar ETS, WAG/Rij kontrol ve WAG/Rij ETS gruplarına ayrılmıştır (n=20). ETS grupları 3 ay boyunca kronik ETS tedavisi (oral, 300 mg/kg/gün) almışlardır. Üç aylık tedavi periyodunun sonunda EEG kayıtları kullanılarak diken dalga deşarjlarının (DDD) toplam süre, ortalama süre ve sayısı değerlendirilmiştir. Ortalama arteriyel kan basıncı (OAB) ve kalp hızı (KH) ölçümleri gerçekleştirilmiştir. Bulgular: ETS tedavisi WAG/Rij sıçanlarda DDD’leri toplam süre, ortalama süre ve sayı açısından anlamlı olarak azaltmıştır. OAB, WAG/Rij kontrol grubunda Wistar kontrol grubuna göre anlamlı olarak artmıştır. KH, Wistar ETS grubunda Wistar kontrol grubuna göre anlamlı olarak azalmıştır. KCl aracılı kasılma yanıtlarında Wistar kontrol grubuna göre Wistar ETS grubunda anlamlı artma, WAG/Rij kontrol grubunda anlamlı azalma saptanmıştır. Sonuç: Sonuçlarımız OAB ve vasküler reaktivitenin WAG/Rij sıçanlarda arttığını göstermiştir. ETS tedavisi, WAG/Rij sıçanlarda kardiyovasküler parametreleri değiştirmezken Wistar sıçanlarda KH ve vasküler reaktiviteyi azaltmış OAB’yi etkilememiştir. Bu değişikliklerde T-tipi Ca++ kanallarının rol oynayabileceği düşünülmektedir.

🔖

Cite This Article

ŞAHİN, T. D., UTKAN, T., KARSON, A., YAZIR, Y., KARAOZ, E. (2020). Cardiovascular changes in genetic absence epileptic WAG/Rij rats: Effects of chronic ethosuximide treatment. Cukurova Medical Journal, Cilt: 45 - Sayı: 3, 769–777. https://ajindex.com/articles/105813

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Jansen K, Lagae L. Cardiac changes in epilepsy. Seizure. 2010;19:455-60
  2. Velagapudi P, Turagam M, Laurence T, Kocheril A. Cardiac arrhythmias and sudden unexpected death in epilepsy (SUDEP). Pacing Clin Electrophysiol. 2012;35:363-70
  3. Depaulis A, Charpier S. Pathophysiology of absence epilepsy: Insights from genetic models. Neurosci Lett. 2018;667:53-65
  4. Depaulis A, van Luijtelaar G. Genetic models of absence epilepsy in the rat. In Models of Seizures and Epilepsy (Eds A Pitkänen, PA Schwartkroin, SL Moshe):233-248. Amsterdam, Elsevier, 2006
  5. Karson AB, Aker R, Ateş N, Onat F. Cardiovascular effects of intracerebroventricular bicuculline in rats with absence seizures. Epilepsy Res. 1999;34:231-9
  6. Aker RG, Onat FY. Cardiovascular regulation through hypothalamic GABA(A) receptors in a genetic absence epilepsy model in rat. Epilepsia. 2002;43:107-14
  7. Yananli HR, Terzioğlu B, Goren MZ, Aker RG, Aypak C, Onat FY. Extracellular hypothalamic gamma-aminobutyric acid (GABA) and L-glutamic acid concentrations in response to bicuculline in a genetic absence epilepsy rat model. J Pharmacol Sci. 2008;106:301-9
  8. Powell KL, Jones NC, Kennard JT, Ng C, Urmaliya V, Lau S et al. HCN channelopathy and cardiac electrophysiologic dysfunction in genetic and acquired rat epilepsy models. Epilepsia. 2014;55:609-20
  9. Cheong E, Shin HS. T-type Ca++ channels in absence epilepsy. Biochim Biophys Acta. 2013;1828:1560-71
  10. Kessler SK, McGinnis E. A practical guide to treatment of childhood absence epilepsy. Paediatr Drugs. 2019;21:15-24
  11. Russo E, Citraro R, Scicchitano F, De Fazio S, Di Paola ED, Constanti A et al. Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia. 2010;51:1560-9
  12. Blumenfeld H, Klein JP, Schridde U, Vestal M, Rice T, Khera DS et al. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia. 2008;49:400-9
  13. Sarkisova KY, Kuznetsova GD, Kulikov MA, van Luijtelaar G. Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia. 2010;51:146-60
  14. Crunelli V, Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci. 2002;3:371-82
  15. Perez-Reyes E. Molecular physiology of low-voltageactivated t-type calcium channels. Physiol Rev. 2003;83:117-61
  16. Kim D, Song I, Keum S, Lee T, Jeong MJ, Kim SS et al